Evidence map›Paper›PMID 40722427›Full record

ArticleBioengineering (Basel, Switzerland)2025

Residual-Free Micro-Nano Titanium Surfaces via Titanium Blasting and Single Acid-Etching: A Cleaner Alternative.

Artiom Lijnev, José Eduardo Maté Sánchez de Val, Jeevithan Elango, Carlos Pérez-Albacete Martínez, José Manuel Granero Marín, Antonio Scarano, Sergio Alexandre Gehrke

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Artiom LijnevDepartment of Biomaterials Engineering, Faculty of Health Sciences, Universidad Católica de Murcia UCAM, Campus de los Jerónimos 135, 30107 Murcia, Spain.ORCID 0000-0001-5560-9508
José Eduardo Maté Sánchez de ValDepartment of Biomaterials Engineering, Faculty of Health Sciences, Universidad Católica de Murcia UCAM, Campus de los Jerónimos 135, 30107 Murcia, Spain.ORCID 0000-0002-4216-421X
Jeevithan ElangoDepartment of Biomaterials Engineering, Faculty of Health Sciences, Universidad Católica de Murcia UCAM, Campus de los Jerónimos 135, 30107 Murcia, Spain.ORCID 0000-0003-4115-9918
Carlos Pérez-Albacete MartínezDepartment of Biomaterials Engineering, Faculty of Health Sciences, Universidad Católica de Murcia UCAM, Campus de los Jerónimos 135, 30107 Murcia, Spain.ORCID 0000-0002-1246-5185
José Manuel Granero MarínDepartment of Implant Dentistry, Faculty of Medicine and Dentistry, UCAM-Universidad Católica San Antonio de Murcia, 30107 Murcia, Spain.ORCID 0000-0001-5916-1237
Antonio ScaranoDepartment of Innovative Technologies in Medicine & Dentistry, University of Chieti-Pescara, 66013 Chieti, Italy.ORCID 0000-0003-1374-6146
Sergio Alexandre GehrkeDepartment of Implantology, Bioface/Postgrados en Odontología/Universidad Católica de Murcia, Montevideo 11100, Uruguay.ORCID 0000-0002-5863-9101

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTraditional sandblasted large-grit acid-etched (SLA) surface treatments frequently utilize alumina (Al

methodsGrade IV titanium disks were treated either with TiO

resultsThe combination treatment produced a more homogeneous micro-nano structure with significantly increased roughness and a cleaner surface chemistry. Osteoblast proliferation and metabolic activity were notably improved in the TiO

conclusionsTitanium blasting combined with HCl etching yields a cost-effective, contamination-free surface modification with promising early-stage cellular responses. This approach represents a safer and effective alternative to conventional SLA treatment.

Indexed as

implant surfacein vitro studymicro and micro–nano surfaceosteoblasts

Identifiers

PMID40722427
PMCPMC12292113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.